Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CTSE |
| Upstream (Parents) |
|---|
| (<<) FUT8 → CTSE |
| (<<) F3 → CTSE |
| (<<) DHRS9 → CTSE |
| (<<) MLPH → CTSE |
| (<<) PTGS2 → CTSE |
| (<<) GJB5 → CTSE |
| (<<) GCNT3 → CTSE |
| Downstream (Children) |
|---|
| CTSE → SERPINB2 (>>) |
| CTSE → PRODH (>>) |
| CTSE → PTPRZ1 (>>) |
| CTSE → B3GALT5 (>>) |
| CTSE → KCNH4 (>>) |
| CTSE → PCDHA3 (>>) |
| CTSE → DHRS9 (>>) |
| CTSE → CNPY4 (>>) |
| CTSE → MLPH (>>) |
| CTSE → PTGS2 (>>) |
| CTSE → CCK (>>) |
| CTSE → GJB5 (>>) |
| CTSE → CLDN18 (>>) |
| CTSE → SPINK4 (>>) |
| CTSE → DKK1 (>>) |
| CTSE → KCNMB3 (>>) |
